Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pevonedistat in Combination With Carboplatin and Paclitaxel in Advanced NSCLC Previously Treated With Immunotherapy
NCT03965689Phase 2Active, not recruiting
- Sponsor
- National Cancer Institute
- Start
- Apr 2020
- Primary completion
- Sep 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pevonedistat in non-small cell lung cancer (NSCLC), sponsored by National Cancer Institute. Started Apr 2020; status: active, not recruiting.
02
Drugs
pevonedistat
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT03965689.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03965689.